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The emphasis of all drug discovery and development processes is on a constant push for improvement. In this perspective,
Nicolaou discusses how, in recent years, this push led to the formation of transdisciplinary collaborations between chemistry,
biology, and medicine, and he argues for the need to strengthen these relationships.Perspective on Biologicals as Human Therapies
PAGE 1046
Drug development is an area of intense research interest in which chemistry and biology intersect in a number of different
ways. Murry and Baeuerle provide a perspective on one specific area of this intersection, derivatized biologicals, which
constitute a growing segment of the pharmaceutical/biotech market.Perspective on Aptamers and SELEX
PAGE 1055
Aptamers and SELEX, the method used to identify them, have been of significant in-
terest in both basic and applied science. Mayer and Famulok provide a brief historical
perspective of aptamers, SELEX, and the journalChemistry & Biology and discuss the
current state of the art of aptamer technologies.Perspective on the RNA and DNA Function
PAGE 1059
Over the past 20 years, there have been many remarkable discoveries pertaining to
nucleic acid function. Joyce and Breaker discuss how chemical biologists have
been at the forefront of these discoveries, which encompass functional nucleic acids
in biology and those that have been engineered in the laboratory.Perspective on Chemical Tools to Study Adaptive
Immune System
PAGE 1066
The ability to monitor and manipulate antigen-specific immune responses would have a major impact on several areas of
biology and medicine. Kodadek discusses the use of ‘‘antigen surrogates’’ (synthetic, nonbiological ligands for the anti-
gen-binding sites of antibodies or immune receptors) for this purpose.In Review: Click Chemistry in Complex Mixtures
PAGE 1075
‘‘Click chemistry’’ refers to a synthetic organic chemistry strategy for joining smaller units together with ease and under mild
conditions following examples in nature. This strategy has been prominently used in biological systems with a great deal of
success, and Finn and McKay review recent developments in the field.In Review: Small Molecule Inhibitors of PPIs
PAGE 1102
Targeting protein-protein interactions (PPIs) remains one of the biggest challenges in
drug discovery. Nonetheless, progress continues to bemade, resulting in clinical trials
for six targets. Arkin et al. review the increasing understanding of PPIs and their
druggability over the last decade and comment on the future.In Review: Oral Druggable Space beyond the Rule
of Five
PAGE 1115Many drug discovery efforts use the rule of Five to guide the process of compound prioritization. Doak et al. discuss how anal-
ysis of drugs and clinical candidates having a molecular weight of >500 Da demonstrates opportunities for discovery of orally
bioavailable drugs in physicochemical space far beyond the rule of five (bRo5).Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltd All rights reserved v
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DeLaBarre et al. discuss developing drugs that target cancer cell metabolism and review three targets with central roles in
metabolic pathways crucial for cancer cell growth: pyruvate kinase muscle isozyme splice variant 2 (PKM2), glutaminase,
and isocitrate dehydrogenase 1 and 2 isozymes (IDH1/2).In Review: Screening Technologies for Small
Molecule Discovery
PAGE 1162
Screening has become a commonly used technique in both academia and industry
and has evolved a set of standardized tools and techniques. In this review, Janzen
provides both a historical perspective on how screening evolved as a unique scientific
discipline and a commentary on the current state of the art technologies.In Review: Metabolic Pathways through
Chemoproteomics and Metabolomics
PAGE 1171
Medina-Cleghorn andNomura review how innovativemetabolic mapping techniques have been used to successfully identify,
characterize, and pharmacologically target nodal metabolic pathways important in mammalian physiology and disease.In Review: Chemical Biology Tools for Regulating RAS Signaling
PAGE 1185
Although the molecular details of RAS signaling cascades are well understood, there is still a largely unmet need for small
molecule probes to control RAS signaling in space and time. In this review, van Hattum and Waldmann discuss some of
the innovative chemical biology approaches to regulate RAS signaling.In Review: Small Molecule Control of Chromatin Remodeling
PAGE 1196
Gene transcription is controlled by local changes in chromatin conformation. This chromatin remodeling is effected by
enzyme-catalyzed modifications to chromatin components. Finley and Copeland review development of small molecule
modulators of chromatin remodelers as a basis for therapy in human diseases.In Review: Mining the Metabiome
PAGE 1211
Microbes are a rich source of diverse natural products (NP) that have a wide range of applications. Additionally, metabiome
analyses revealed enormous reservoirs of as yet untapped NP. Milshteyn et al. provide a historical context of microbial NP
discovery and discuss a more recent work on mining the metabiome.vi Chemistry & Biology 21, September 18,In Review: Methods for Investigating GPCRs
PAGE 1224
G protein-coupled receptors (GPCRs) are a large family of membrane proteins that
represent targets for a significant number of available drugs. Huber and Sakmar re-
view chemical biology approaches for studies of GPCR signaling kinetics and dy-
namics that help answer open questions regarding GPCR signaling.In Review: Strategies for Posttranslational Control
of Proteins
PAGE 1238
Technologies that enable direct manipulation of protein levels on a posttransla-
tional basis are of increasing interest as they generally offer precision, speed,and reversibility of modulation. Rakhit et al. review recent advances in chemical biology strategies for controlling protein
levels and comment on potential future developments.2014 ª2014 Elsevier Ltd All rights reserved
